AAAAAA

   
Results: 1-15 |
Results: 15
Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia
Authors: Ricaurte, JC Boucher, HW Turett, GS Moellering, RC LaBombardi, VJ Kislak, JW
Citation: Jc. Ricaurte et al., Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia, CL MICRO IN, 7(1), 2001, pp. 17-21
Maximizing Antimicrobial Efficacy/Minimizing Antimicrobial Resistance: A Paradigm for the New Millennium - Proceedings of a Symposium held at the American Academy of Arts and Sciences, Cambridge, Massachusetts, 7-8 December 1999 - General discussion
Authors: Zinner, SH Wise, R Moellering, RC Acar, J Craig, W Davey, P Garau, J Klugman, K Kristinsson, K Levin, B Low, D MacGowan, A O'Brien, T Osterholm, M Pechere, JC Phillips, I Tenover, F Williams, R Young, L
Citation: Sh. Zinner et al., Maximizing Antimicrobial Efficacy/Minimizing Antimicrobial Resistance: A Paradigm for the New Millennium - Proceedings of a Symposium held at the American Academy of Arts and Sciences, Cambridge, Massachusetts, 7-8 December 1999 - General discussion, CLIN INF D, 33, 2001, pp. S251-S260
Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin
Authors: Linden, PK Moellering, RC Wood, CA Rehm, SJ Flaherty, J Bompart, F Talbot, GH
Citation: Pk. Linden et al., Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin, CLIN INF D, 33(11), 2001, pp. 1816-1823
Prolonged colonization with vancomycin-resistant enterococcus faecium in long-term care patients and the significance of "clearance"
Authors: Baden, LR Thiemke, W Skolnik, A Chambers, R Strymish, J Gold, HS Moellering, RC Eliopoulos, GM
Citation: Lr. Baden et al., Prolonged colonization with vancomycin-resistant enterococcus faecium in long-term care patients and the significance of "clearance", CLIN INF D, 33(10), 2001, pp. 1654-1660
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Authors: Tsiodras, S Gold, HS Sakoulas, G Eliopoulos, GM Wennersten, C Venkataraman, L Moellering, RC Ferraro, MJ
Citation: S. Tsiodras et al., Linezolid resistance in a clinical isolate of Staphylococcus aureus, LANCET, 358(9277), 2001, pp. 207-208
Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer
Authors: Viera, CT Tsiodras, S Gold, HS Coakley, EPG Wennersten, C Eliopoulos, GM Moellering, RC Inouye, RT
Citation: Ct. Viera et al., Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer, ANTIM AG CH, 45(3), 2001, pp. 973-975
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium (Reprinted from The Journal Antimicrobial Chemotherapy, vol 44, pg 251-261, 1999)
Authors: Moellering, RC Linden, PK Reinhardt, J Blumberg, EA Bompart, F Talbot, GH
Citation: Rc. Moellering et al., The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium (Reprinted from The Journal Antimicrobial Chemotherapy, vol 44, pg 251-261, 1999), FORMULARY, 35, 2000, pp. S25-S35
Diversity of domain V of 23S rRNA gene sequence in different Enterococcus species
Authors: Tsiodras, S Gold, HS Coakley, EPG Wennersten, C Moellering, RC Eliopoulos, GM
Citation: S. Tsiodras et al., Diversity of domain V of 23S rRNA gene sequence in different Enterococcus species, J CLIN MICR, 38(11), 2000, pp. 3991-3993
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains
Authors: Queenan, AM Torres-Viera, C Gold, HS Carmeli, Y Eliopoulos, GM Moellering, RC Quinn, JP Hindler, J Medeiros, AA Bush, K
Citation: Am. Queenan et al., SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains, ANTIM AG CH, 44(11), 2000, pp. 3035-3039
Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections
Authors: Moellering, RC
Citation: Rc. Moellering, Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections, J ANTIMICRO, 44, 1999, pp. 25-30
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium
Authors: Moellering, RC Linden, PK Reinhardt, J Blumberg, EA Bompart, F Talbot, GH
Citation: Rc. Moellering et al., The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium, J ANTIMICRO, 44(2), 1999, pp. 251-261
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium
Authors: Schulin, T Thauvin-Eliopoulos, C Moellering, RC Eliopoulos, GM
Citation: T. Schulin et al., Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium, ANTIM AG CH, 43(12), 1999, pp. 2873-2876
A cluster of VanD vancomycin-resistant Enterococcus faecium: Molecular characterization and clinical epidemiology
Authors: Ostrowsky, BE Clark, NC Thauvin-Eliopoulos, C Venkataraman, L Samore, MH Tenover, FC Eliopoulos, GM Moellering, RC Gold, HS
Citation: Be. Ostrowsky et al., A cluster of VanD vancomycin-resistant Enterococcus faecium: Molecular characterization and clinical epidemiology, J INFEC DIS, 180(4), 1999, pp. 1177-1185
A novel antimicrobial agent joins the battle against resistant bacteria
Authors: Moellering, RC
Citation: Rc. Moellering, A novel antimicrobial agent joins the battle against resistant bacteria, ANN INT MED, 130(2), 1999, pp. 155-157
Macrolides and clindamycin
Authors: Gold, HS Moellering, RC
Citation: Hs. Gold et Rc. Moellering, Macrolides and clindamycin, CLINICAL INFECTIOUS DISEASES, 1999, pp. 291-297
Risultati: 1-15 |